Jun-15 – Ataxia



We are pleased to announce a new partnership between Pfizer, Ataxia UK and three academic institutions on a new friedreich’s ataxia drug discovery project 

A new drug discovery project, funded by the pharmaceutical company Pfizer and Ataxia UK, will involve researchers from UCL, Imperial College London and Oxford University. The aim of the collaboration is to find a new drug therapy for people with Friedreich’s ataxia. 

Posted: 30/06/2015

Horizon Pharma plc begins phase 3 trial of ACTIMMUNE® for the treatment of people with friedreich’s ataxia

A phase 3 study to identify the safety, efficacy and tolerability of the drug ACTIMMUNE® (Interferon gamma-1b) on people with FA has been initiated.

Posted: 16/06/2015

Report on the interview with Pavel Balabanov from the European Medicines Agency (EMA)

Take a look at what Dr Blabanov had to say about drug development at our conference. He is a scientific administrator for the EMA, who evaluate medicinal products in Europe.

Posted: 12/06/2015


Something went wrong. Please check your entries and try again.
fundraise image


Take part in a challenge or create your fundraiser. Every penny you raise will help those affected by ataxia.

Donate Image


To make either a one off or recurring donation which will help fund research into treatments and cures and supports those affected ataxia

Volunteer Image


Support the ataxia community and volunteer with Ataxia UK. From social media to telephone befriending, there are loads of ways you can make a difference to someone's life.

Donate Now
Welcome to our new site! We hope you like it.
As it's brand new, there may be a few temporary glitches such as broken links - we are working on getting these all fixed ASAP. If you'd like to give us any feedback or let us know if something isn't quite right, please email website@ataxia.org.uk
Scroll to Top